Luminate: Completed Phase IIb enrollment

Allegro completed enrollment of 120 patients in the double-blind, placebo-controlled, U.S. Phase IIb DEL MAR trial comparing 1, 2

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE